Effects of Neurexan on Stress-Induced Changes of Spectral EEG Power: A Double-Blind, Randomized, Placebo-Controlled, Crossover Exploratory Trial in Human Volunteers
Neurexan is a multicomponent natural medicinal product？used？for？stress-related？symptoms such as nervous restlessness and insomnia. The present study？investigated？the？efficacy？of Neurexan on stress-induced changes of brainwave frequencies？using quantitative analysis of spectral EEG power. Thirty healthy male and female volunteers were tested in a randomized, placebo controlled cross-over trial under conditions of relaxation and experimental stress-in-？duction. Recording of the EEG was performed over four hours after drug administration. Data was？analyzed using the proprietary fast dynamic EEG technology Neurocode-Tracking. Quantitative EEG revealed a task dependent increase of beta2 power as a surrogate parameter of stress induced anxiety. The elevated frontotemporal beta2 power was ameliorated by intake of Neurexan during the second and third hour after administration. This indicates that Neurexan is effectively helping subjects to better cope with task-related stress situations.
References
[1]
Wiegner, L., et al. (2015) Prevalence of Perceived Stress and Associations to Symptoms of Exhaustion, Depression and Anxiety in a Working Age Population Seeking Primary Care—An Observational Study. BMC Family Practice, 16, 38.
https://doi.org/10.1186/s12875-015-0252-7
[2]
European Risk Observatory Report (2009) OSH in Figures: Stress at Work Facts and Figures. https://osha.europa.eu/en/tools-and-publications/publications
[3]
Doering, B.K., et al. (2016) Effects of Neurexan in an Experimental Acute Stress Setting—An Explorative Double-Blind Study in Healthy Volunteers. Life Sciences, 146, 139-147. https://doi.org/10.1016/j.lfs.2015.12.058
[4]
Waldschutz, R. and Klein, P. (2008) The Homeopathic Preparation Neurexan vs. Valerian for the Treatment of Insomnia: An Observational Study. The Scientific World Journal, 8, 411-420. https://doi.org/10.1100/tsw.2008.61
[5]
Hubner, R., van Haselen, R. and Klein, P. (2009) Effectiveness of the Homeopathic Preparation Neurexan Compared with That of Commonly Used Valerian-Based Preparations for the Treatment of Nervousness/Restlessness—An Observational Study. The ScientificWorld Journal, 9, 733-745. https://doi.org/10.1100/tsw.2009.95
[6]
Saletu, B., Grunberger, J. and Linzmayer, L. (1983) Quantitative Pharmaco-EEG and Performance after Administration of Brotizolam to Healthy Volunteers. British Journal of Clinical Pharmacology, 16, 333S-345S.
https://doi.org/10.1111/j.1365-2125.1983.tb02308.x
[7]
Dimpfel, W., Todorova, A. and Vonderheid-Guth, B. (1999) Pharmacodynamic Properties of St. John’s Wort—A Single Blind Neurophysiological Study in Healthy Subjects Comparing Two Commercial Preparations. European Journal of Medical Reserach, 4, 303-312.
[8]
Schober, F., Schellenberg, R. and Dimpfel, W. (1995) Reflection of Mental Exercise in the Dynamic Quantitative Topographical EEG. Neuropsychobiology, 31, 98-112.
https://doi.org/10.1159/000119179
[9]
Corradini, P.L. and Persinger, M.A. (2015) Replace Psychometric Inferences with Direct Brain Measurements: LORETA Reflects Traditional Cerebral Loci for Neuropsychological Tests. Neuroscience and Medicine, 6, 107-115.
https://doi.org/10.4236/nm.2015.630187
[10]
Dimpfel, W., Koch, K. and Weiss, G. (2012) Single Dose Effects of Pascoflair on Current Source Density (CSD) of Human EEG. Neuroscience & Medicine, 3, 130-140. https://doi.org/10.4236/nm.2012.32018
[11]
Ferber, G., et al. (1999) IPEG Guideline on Statistical Design and Analysis for Pharmaco-Dynamic Trials. Neuropsychobiology, 39, 92-100.
https://doi.org/10.1159/000026567
[12]
Dimpfel, W. and Hofmann, H.C. (2014) Neurocode-Tracking Based on Quantitative Fast Dynamic EEG Recording in Combination with Eye-Tracking. World Journal of Neuroscience, 4, 106-119. https://doi.org/10.4236/wjns.2014.42013
[13]
Dimpfel, W., et al. (1996) Source Density Analysis of Functional Topographical EEG: Monitoring of Cognitive Drug Action. European Journal of Medical Research, 1, 283-290.
[14]
Grulke, N., et al. (2006) Standardization of the German Short Version of “Profile of Mood States” (POMS) in a Representative Sample-Short Communication. Psychotherapie, Psychosomatik, Medizinische Psychologie, 56, 403-405.
[15]
Schutter, D.J., et al. (2001) Parietal Electroencephalogram Beta Asymmetry and Selective Attention to Angry Facial Expressions in Healthy Human Subjects. Neuroscience Letters, 314, 13-16. https://doi.org/10.1016/S0304-3940(01)02246-7
[16]
Dimpfel, W., Wedekind, W. and Keplinger, I. (2003) Gender Difference in Electrical Brain Activity during Presentation of Various Film Excerpts with Different Emotional Content. European Journal of Medical Research, 8, 192-198.
[17]
Dimpfel, W. (2008) Pharmacological Modulation of Dopaminergic Brain Activity and Its Reflection in Spectral Frequencies of the Rat Electropharmacogram. Neuropsychobiology, 58, 178-186. https://doi.org/10.1159/000191124
[18]
Stipacek, A., et al. (2003) Sensitivity of Human EEG Alpha Band Desynchronization to Different Working Memory Components and Increasing Levels of Memory Load. Neuroscience Letters, 353, 193-196.
https://doi.org/10.1016/j.neulet.2003.09.044
[19]
Cummings, L., Dane, A., Rhodes, J., Lynch, P. and Hughes, A.M. (2000) Diurnal Variation in the Quantitative EEG in Healthy Adult Volunteers. British Journal of Clinical Pharmacology, 50, 21-26. https://doi.org/10.1046/j.1365-2125.2000.00205.x
